Statistical evaluation of stability data of pharmaceutical products for specification setting

Drug Development and Industrial Pharmacy

Volumn 23, Issue 5, 1997, Pages 427-439

  Wessels, Peter ^a   Holz, Martin ^b   Erni, Fritz ^a   Krummen, Kurt ^a   Ogorka, Joerg ^a  

^a Sandoz Pharma Ltd   (Switzerland)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG STABILITY; INFORMATION PROCESSING; REVIEW; RISK ASSESSMENT; STATISTICS; STORAGE;

EID: 0030912477     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709148492     Document Type: Review

References (24)

1. ICH Harmonized Tripartite Guideline, Stability Testing of New Drug Substances and Products, Endorsed by the ICH Steering Committee at Step 4 of the ICH Process, October 27, 1993.
2. Center for Drugs and Biologics, Food and Drug Administration, U.S. Department of Health and Human Services, Guideline for Submitting Documentation for the Stability of Human Drugs and Biologics, Washington, DC, 1987.
3. J. T. Carstensen, Drug Stability - Principles and Practices, Marcel Dekker, New York, 1990.
4. D. J. Schuirmann, in AAPS/FDA Conference, Proceedings: Stability Guidelines for Testing Pharmaceutical Products: Issues and Alternatives, Arlington, VA, 1989.
5. N. Delclos, F. Pellerin, M. Aubert, R. Bentejac, C. Bullot, J. L. Colin, A. M. Gallo, P. Grelet, V. Labbe, G. Lenay, F. Malfroid, R. Russotto, and H. Vrinat, STP Pharma Pratiq., 4, 91 (1994).
6. D. L. Bentley, J. Pharm. Sci., 59, 464 (1970).
7. O. L. Davies and H. E. Hundson Statistics in Pharmacy, Marcel Dekker, New York, 1981.
8. S. P. King, M. Kung, and H. Fung, J. Pharm. Sci., 73, 657 (1984).
9. V. Hartmann, K. Krummen, G. Schnabel, and H. Bethke, Pharm. Ind., 44, 71 (1982).
10. J. T. Carstensen and E. Nelson, J. Pharm. Sci., 65, 311 (1976).
11. F. Langenbucher, Drug Dev. Ind. Pharm., 17, 165 (1991).
12. S. C. Chow and J. Shao, Stat. Med., 8, 883 (1989).
13. J. J. Chen, J. S. Hwang, and Y. Tsong, J. Biopharm. Stat., 5, 131 (1995).
14. T. E. Norwood, Drug Dev. Ind. Pharm., 12, 553 (1986).
15. O. L. Davies and P. L. Goldsmith, Statistical Methods in Research and Production, Longman Scientific & Technical, Essex, 1988.
16. A. A. Afifi and S. P. Azen, Statistical Analysis: A Computer Oriented Approach, Academic Press, New York, 1979.
17. S. J. Ruberg and J. W. Stegeman, Biometrics, 47, 1059 (1991).
18. P. B. Patnaik, Biometrika, 36, 202 (1949).
19. H. Peil and V. Haeselbarth, Drug Res., 35, 1489 (1985).
20. J. Zar, Biostatistical Analysis, Prentice-Hall, Englewood Cliffs, NJ, 1984.
21. W. G. Cochran and G. M. Cox, Experimental Designs, Wiley & Sons, New York; Chapman & Hall, London, 1957.
22. N. R. Drapper and H. Smith, Applied Regression Analysis, Wiley & Sons, New York, 1966.
23. R. C. Kohberger, in Biopharmaceutical Statistics for Drug Development (K. E. Peace, ed.), Marcel Dekker, New York, 1988.
24. P. V. Allen, G. R. Dukes, and M. E. Gerger, Pharm. Res., 8, 1210 (1991).